PMID: 9188798May 22, 1997Paper

Reactive liposomes encapsulating a glucose oxidase-peroxidase system with antibacterial activity

Biochimica Et Biophysica Acta
K J HillM N Jones

Abstract

Liposomes were prepared from phospholipid mixtures of dipalmitoylphosphatidylcholine (DPPC) and phosphatidylinositol (PI), encapsulating the enzymes glucose oxidase (GO) and GO in combination with horse radish peroxidase (HRP) by both extrusion (VET) and reverse-phase evaporation (REV). The optimum level of PI in DPPC/PI liposomes for targeting to biofilms of the oral bacterium Streptococcus gordonii has been established. The liposomes were characterised in terms of the content and activity of the encapsulated enzymes. The antibacterial activity of these 'reactive' liposomes arising from hydrogen peroxide and oxyacids in the presence of the substrates glucose and iodide ions, after targeting to the biofilms, were measured both as a function of liposome-biofilm incubation time and incubation time with the substrates. Bacterial inhibition increases with both liposome-biofilm and substrate-biofilm incubation time and with the extent of enzyme encapsulation. The reactive liposomes also display antibacterial activity in the presence of saliva. The reactive liposomes have potential value in the context of oral hygiene.

References

Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·F Szoka, D Papahadjopoulos
Jun 13, 1986·Biochimica Et Biophysica Acta·L D MayerP R Cullis
Mar 28, 1966·Biochimica Et Biophysica Acta·S J KlebanoffR G Luebke

❮ Previous
Next ❯

Citations

Aug 29, 2006·BMC Oral Health·James D Bryers, Buddy D Ratner
Aug 16, 2013·International Journal of Nanomedicine·Ramanathan K KasimanickamJohn P Kastelic
Mar 18, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shunmugaperumal TamilvananAnnick Ludwig
May 20, 2015·Advanced Drug Delivery Reviews·Yang LiuYunfeng Lu
Jul 4, 2015·Nanomedicine·Dave Wei-Chih Chen, Shih-Jung Liu
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Katrien ForierKevin Braeckmans
May 28, 2016·Pharmaceutics·Zora Rukavina, Željka Vanić
Jan 25, 2017·ACS Applied Materials & Interfaces·Maria Godoy-GallardoLeticia Hosta-Rigau
Jun 21, 2017·Molecular Biotechnology·Fatemeh Khadivi DerakshanCatherine Madzak
Jul 25, 2000·Journal of Pharmaceutical Sciences·J F LiangV C Yang
Jul 27, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Lai Truong PhuocAnne Galarneau
Jun 5, 2020·Future Microbiology·Gratiela G Pircalabioru, Mariana-Carmen Chifiriuc
Mar 1, 2014·Biophysics Reviews·Manuel AhumadaEduardo Lissi
Dec 8, 2016·Drug Delivery and Translational Research·Kamal DuaPhilip M Hansbro
Mar 7, 2008·Sensors·Dorothee GrieshaberErik Reimhult
Jan 23, 2013·Physical Chemistry Chemical Physics : PCCP·Shuji FujitaKenji Kano
Mar 27, 2021·Drug Delivery and Translational Research·Sevda ŞenelGülçin Akca
Apr 14, 2005·Chemical Reviews·Dennis M VriezemaRoeland J M Nolte
Apr 12, 2021·Biotechnology and Applied Biochemistry·Seyyed Hossein KhatamiAhmad Movahedpour
Jul 17, 1999·Biochimica Et Biophysica Acta·M Kaszuba, M N Jones
Sep 29, 2001·Biomolecular Engineering·P Walde, S Ichikawa
Feb 20, 2014·ACS Applied Materials & Interfaces·Tomotaka Natsume, Makoto Yoshimoto
May 14, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Makoto YoshimotoTakayuki Okita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.